Hrt Financial LP Isoray, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	101,895 Added 502.64%	122,167 $84,000
Q4 2023 Feb 09, 2024	SELL	N/A	-82,436 Reduced 80.26%	20,272 $8,000
Q3 2023 Nov 13, 2023	BUY	N/A	102,708 New	102,708 $28,000
Q4 2022 Feb 10, 2023	BUY	$0.24 - $0.4 $7,245 - $12,075	30,189 New	30,189 $7,000
Q1 2021 May 17, 2021	SELL	$0.53 - $2.47 $33,360 - $155,474	-62,945 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.36 - $0.58 $15,962 - $25,716	44,339 Added 238.3%	62,945 $28,000
Q3 2020 Nov 13, 2020	BUY	$0.54 - $0.78 $10,047 - $14,512	18,606 New	18,606 $10,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.